Alphabet Inc GOOGL 0.07%’s reign as the world’s largest public company was very short-lived. After the stock briefly eclipsed Apple Inc. AAPL 0.6% as the world’s largest public company following a solid Q4 earnings beat, Alphabet’s market cap has now plummeted more than 15 percent in a matter of days.

There’s no question that modern technology and science has extended the average life expectancy of the human race. While more years spent with loved ones and longer, richer lives is certainly a good thing, an aging population comes with unprecedented healthcare needs. Healthcare is already more than a $3 trillion business in the U.S. alone,…

LinkedIn Corp LNKD 1.68% capped off a horrendous week with a 43.6 percent decline on Friday after a major earnings miss spooked the market. Unfortunately, CNBC analyst Jim Cramer believes that the stock’s freefall may not be over yet.

Credit Suisse knows true global diversification goes beyond simply owning U.S. stocks in different business sectors. The firm maintains a list of around 40 of its best global investment ideas, and it recently released a report containing the newest updates.

The latest credit default swap (CDS) data from BMO Capital Markets indicate a number of investors are growing increasingly concerned about the one-year outlook for capital markets. In a new report, analyst Mark Steele discussed the recent surge in one-year CDS activity, and what it means for the market.

Typically, a stock that has declined as much as GoPro Inc GPRO 3.97%’s stock has will inspire a swing in value-driven or contrarian bullish sentiment in the market. However, as GoPro’s stock dips into the single digits, down more than 80 percent in the past year, the latest data from StockTwits shows that there is…

ETFs offer investors the ability to invest in a particular theme while maintaining the protection of diversification. However, when one company expands its business so much that it has its claws in every aspect of a particular market, it can become almost like an ETF unto its own.

Leerink has restarted coverage on eight large-cap biotech stocks following a prolonged period of share price underperformance. In a new report, analyst Geoffrey Porges explained why now is the time to buy back into biotech, but investors still must be selective.

In a new report, Oppenheimer analyst Timothy Horan explained why he expects cloud adoption to accelerate in a major way in 2016. According to Horan, the cloud is now entering the steepest part of its “s-curve” adoption cycle, and Oppenheimer anticipates a 20 percent boost in cloud capex in 2016 as well as a 35…